Concert Pharmaceuticals CEO Roger Tung's 2021 pay rises 17% to $3.5M
Concert Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Concert Pharmaceuticals reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Concert Pharmaceuticals received on average a compensation package of $2.1M, a 9% increase compared to previous year.
Average pay of disclosed executives at Concert Pharmaceuticals
Roger D. Tung, Chief Executive Officer, received $3.5M in total, which increased by 17% compared to 2020. 47% of Tung's compensation, or $1.6M, was in option awards. Tung also received $368K in non-equity incentive plan, $599K in salary, $906K in stock awards, as well as $12K in other compensation.
James V. Cassella, Chief Development Officer, received a compensation package of $1.5M, which increased by 18% compared to previous year. 32% of the compensation package, or $484K, was in option awards.
Marc Becker, Chief Financial Officer, earned $1.4M in 2021.
Related executives
You may also like
Source: SEC filing on April 26, 2022.